PPARgamma agonist-23 (Compound 9) is an orally active PPARgamma agonist with an EC50 of 0.32 µM. PPARgamma agonist-23 improves hepatic triglyceride levels, reduces scores of steatosis and hepatocellular ballooning, and decreases the total activity score of non-alcoholic steatohepatitis (NASH). PPARgamma agonist-23 can be used for the research of non-alcoholic steatohepatitis[1].
Molekulargewicht:
526.61
Formel:
C28H18D7NO7S
Target-Kategorie:
PPAR
Anwendungsbeschreibung:
MCE Product type: Isotope-Labeled Compounds
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
